These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34287992)

  • 21. Treatment of benign prostate hyperplasia using the Rezum® water vapor therapy system: Results at one year.
    Alegorides C; Fourmarier M; Eghazarian C; Lebdai S; Chevrot A; Droupy S
    Prog Urol; 2020 Oct; 30(12):624-631. PubMed ID: 32826195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rezūm therapy for ≥80-mL benign prostatic enlargement: a large, multicentre cohort study.
    Elterman D; Bhojani N; Vannabouathong C; Chughtai B; Zorn KC
    BJU Int; 2022 Oct; 130(4):522-527. PubMed ID: 35466513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients.
    Bausch K; Zahiti L; Schrutt M; Wetterauer C; Halbeisen FS; Ebbing J; Seifert HH
    World J Urol; 2023 Jun; 41(6):1605-1612. PubMed ID: 37140664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors and Real-World Short-Term Outcomes of a Failed Trial of Void After Rezum Therapy in a Multiethnic Population.
    Babar M; Labagnara K; Loloi J; Tang K; Ines M; Singh S; Iqbal N; Ciatto M
    J Endourol; 2023 Jan; 37(1):67-73. PubMed ID: 36029212
    [No Abstract]   [Full Text] [Related]  

  • 25. Feedback microwave thermotherapy with the ProstaLund Compact Device for obstructive benign prostatic hyperplasia: 12-month response rates and complications.
    Alivizatos G; Ferakis N; Mitropoulos D; Skolarikos A; Livadas K; Kastriotis I
    J Endourol; 2005; 19(1):72-8. PubMed ID: 15735388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience.
    Elterman DS; Bhojani N; Vannabouathong C; Chughtai B; Zorn KC
    Can J Urol; 2022 Apr; 29(2):11075-11079. PubMed ID: 35429425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rezūm® steam system.
    Fernández-Guzmán E; Asensio Matas A; Capape Poves V; Rioja Zuazu J; Garrido Abad P; Martínez-Salamanca JI; Quintana Franco LM; Justo-Quintas J; Romero-Otero J; Domínguez-Esteban M
    Actas Urol Esp (Engl Ed); 2022 Jun; 46(5):310-316. PubMed ID: 35570100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Is New with Rezūm Water Vapor Thermal Therapy for LUTS/BPH?
    Doppalapudi SK; Gupta N
    Curr Urol Rep; 2021 Jan; 22(1):4. PubMed ID: 33403529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up.
    Thulasidasan N; Kok HK; Elhage O; Clovis S; Popert R; Sabharwal T
    Clin Radiol; 2019 Jul; 74(7):569.e1-569.e8. PubMed ID: 30955835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procedural techniques and multicenter postmarket experience using minimally invasive convective radiofrequency thermal therapy with Rezūm system for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Darson MF; Alexander EE; Schiffman ZJ; Lewitton M; Light RA; Sutton MA; Delgado-Rodriguez C; Gonzalez RR
    Res Rep Urol; 2017; 9():159-168. PubMed ID: 28861405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience.
    Mollengarden D; Goldberg K; Wong D; Roehrborn C
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):379-385. PubMed ID: 29282358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world four-year functional and surgical outcomes of Rezum therapy in younger versus elderly men.
    Zhu M; Babar M; Hawks-Ladds N; Tawfik MM; Loloi J; Labagnara K; Sayed R; Tang K; Salami A; Singh S; Singh J; Ines M; Iqbal N; Ciatto M
    Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):109-115. PubMed ID: 37620427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GreenLight laser photoselective vaporization of the prostate for treatment of benign prostate hyperplasia/lower urinary tract symptoms in patients with different post-void residual urine.
    Luo F; Sun HH; Su YH; Zhang ZH; Wang YS; Zhao Z; Li J
    Lasers Med Sci; 2017 May; 32(4):895-901. PubMed ID: 28293871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review.
    Wong A; Mahmalji W
    Aging Male; 2020 Dec; 23(5):1620-1626. PubMed ID: 33818292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia?
    McVary KT; Rogers T; Mahon J; Gupta NK
    J Sex Med; 2018 Dec; 15(12):1728-1738. PubMed ID: 30446471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rezum Outcomes in Relationship to Number of Injections: Is Less More?
    Babar M; Loloi J; Azhar U; Tang K; Ines M; Singh S; Iqbal N; Ciatto M
    J Endourol; 2023 Feb; 37(2):157-164. PubMed ID: 36112665
    [No Abstract]   [Full Text] [Related]  

  • 39. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.